Lin Wei is Chief Medical Officer at Revolution Medicines, Inc. (RVMD). They have made 1 open-market trade across 1 company since 2024, most recently 2026-03-17.
CIK 0001872772
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RVMD | SELL · 10b5-1 | 2026-03-17 | 2026-03-19 | $99.48 | $412K | -0.7% | +49.3% | +61.1% |
| RVMD | SELL · 10b5-1 | 2025-09-16 | 2025-09-18 | $45.82 | $198K | +2.6% | +18.7% | +68.6% |
| RVMD | SELL · 10b5-1 | 2025-06-16 | 2025-06-18 | $39.83 | $173K | -7.8% | -4.2% | +11.8% |
| RVMD | SELL | 2024-06-17 | 2024-06-20 | $37.39 | $418K | -0.6% | +27.5% | +17.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.